The LATERA implant is absorbed over a period of approximately 18-24 months. Post implantation, a fibrous capsule forms and the integrity of the implant is maintained through 12 months. Tissue encapsulation promotes acute implant stability and enables localized tissue response during the absorption process. Remodeling occurs once the implant is replaced with fibrous collagen construct to provide ongoing support.2
The LATERA implant is inserted with a 16-gauge cannula delivery device and supports the upper and lower lateral cartilage by anchoring above the maxilla to provide cantilever support.
|LATERA absorbable nasal implant system||LATSYS20||20 mm, 1 system|
|LATERA absorbable nasal implant system||LATSYS24||24 mm, 1 system|
1 system includes: 1 implant delivery device, 2 absorbable nasal implants
Patients treated with the Latera absorbable nasal implant showed significant improvement in symptoms when measured with the nasal obstruction symptom evaluation (NOSE) score.3
While individual results may vary, patients treated with LATERA absorbable nasal implant experienced the following symptom improvements:1
Patients experienced a reduction in nasal obstruction symptoms of 57.7% at two years, as measured by the NOSE survey. Patients achieved these results without negative cosmetic effects.6
Risks included temporary symptoms such as:7
Other risks related to the LATERA implant included: discomfort, infection, reaction to material and surgical implant removal.9
In a clinical study, patients experienced no long-term adverse cosmetic changes with the LATERA implant.1
* Individual patient results may vary and may include other procedures. Use of the LATERA device in conjunction with other procedures (such as septoplasty and/or turbinate reduction) has not been clinically evaluated. Patient satisfaction results may be attributed to LATERA with other procedures.